Understand the source comparison
Best Peptides to Lose Weight Without Exercise Ranked: Performance Comparison
This table ranks peptides by fat loss efficacy in sedentary protocols based on clinical trial data and mechanism of action. Tirzepatide Dual GIP/GLP-1 agonist. Appetite suppression + delayed gastric emptying 20.9% at 72 weeks (SURMOUNT-1, 15mg weekly) No. Work
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- This table ranks peptides by fat loss efficacy in sedentary protocols based on clinical trial data and mechanism of action.
- Tirzepatide
- Dual GIP/GLP-1 agonist. Appetite suppression + delayed gastric emptying
- 20.9% at 72 weeks (SURMOUNT-1, 15mg weekly)
- No. Works through caloric deficit alone
- GI side effects (nausea, vomiting, diarrhea) in 30–45% during titration
- Highest efficacy for sedentary fat loss. Mechanism is appetite-independent
- Semaglutide
- GLP-1 receptor agonist. Appetite suppression + gastric slowing
- 14.9% at 68 weeks (STEP-1, 2.4mg weekly)
- No. Appetite suppression drives deficit
- GI side effects similar to tirzepatide but slightly lower incidence
- Second-tier efficacy but well-studied. FDA-approved for weight management
- CJC-1295 + Ipamorelin
- Growth hormone secretagogue. Lipolysis via hormone-sensitive lipase
- Minimal without training stimulus (observational data)
- Yes. Lipolysis requires downstream oxidation
- Flushing, tingling, water retention
- Low efficacy without exercise. Mechanism depends on energy expenditure
- Tesofensine
- Serotonin-norepinephrine-dopamine reuptake inhibitor
- 9.2% at 24 weeks (Phase 2 trials, 0.5mg daily)
- No. Increases basal metabolic rate
- Insomnia, increased heart rate, dry mouth
- Moderate efficacy but less studied than GLP-1 agonists. Regulatory status unclear